发明授权
- 专利标题: Heterocyclic compounds and their uses
- 专利标题(中): 杂环化合物及其用途
-
申请号: US13884698申请日: 2011-11-17
-
公开(公告)号: US08765768B2公开(公告)日: 2014-07-01
- 发明人: Timothy David Cushing , Julia Winslow Lohman , Youngsook Shin
- 申请人: Timothy David Cushing , Julia Winslow Lohman , Youngsook Shin
- 申请人地址: US CA Thousand Oaks
- 专利权人: Amgen Inc.
- 当前专利权人: Amgen Inc.
- 当前专利权人地址: US CA Thousand Oaks
- 代理商 Richard V. Person
- 国际申请: PCT/US2011/061141 WO 20111117
- 国际公布: WO2012/068343 WO 20120524
- 主分类号: A01N43/54
- IPC分类号: A01N43/54 ; C07D239/42 ; C07D401/04 ; A61K31/506
摘要:
Substituted bicyclic heteroaryls having the general formula (I) and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p1 108 activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML), Myelodysplastic syndrome (MDS), myelo-proliferative diseases (MPD), Chronic Myeloid Leukemia (CML), T-cell Acute Lymphoblastic leukaemia (T-ALL), B-cell Acute Lymphoblastic leukaemia (B-ALL), Non Hodgkins Lymphoma (NHL), B-cell lymphoma and solid tumors, such as breast cancer.
公开/授权文献
- US20130231352A1 HETEROCYCLIC COMPOUNDS AND THEIR USES 公开/授权日:2013-09-05
信息查询
IPC分类: